Evidence map›Paper›PMID 38313176›Full record

ArticleJournal of medicine and life2023

Neuroprotective effects of Coenzyme Q10 in ischemia-reperfusion injury via inflammation and oxidative stress reduction in adult male rats.

Zainab Ali Fakharaldeen, Ahmed Al-Mudhafar, Sarmad Nory Gany, Ali Nisoom Radhi, Najah Rayish Hadi

Open access · diamondAbstract read
In one paragraph

Article in Journal of medicine and life, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Coenzyme Q10 and Intracellular Signalling Pathways: Clinical Relevance.International journal of molecular sciences · 2025
    Review
  3. Review
  4. From Stress to Synapse: The Neuronal Atrophy Pathway to Mood Dysregulation.International journal of molecular sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zainab Ali FakharaldeenDepartment of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq.
Ahmed Al-MudhafarDepartment of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq.
Sarmad Nory GanyDepartment of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq.
Ali Nisoom RadhiAl-Hakeem Hospital, Al-Najaf Al-Ashraf, Iraq.
Najah Rayish HadiDepartment of Pharmacology and Therapeutics, Faculty of Medicine, University of Kufa, Najaf, Iraq.
University of Kufa · IQ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to investigate the potential neuroprotective effects of coenzyme Q10 in cerebral ischemia-reperfusion injury-induced neuronal damage and explore the underlying mechanisms. Twenty-eight adult male rats, weighing approximately 200-300 grams, were randomly divided into four groups: the sham group (neck dissection without ischemia), the control group (30 minutes of bilateral common carotid artery ligation followed by one hour of reperfusion), the vehicle group (oral carboxymethylcellulose solution for seven days prior to bilateral common carotid artery ligation and reperfusion), and the treatment group (seven days of coenzyme Q10 pretreatment followed by bilateral common carotid artery occlusion and reperfusion). Histopathological analysis and measurement of brain infarct size were performed, and cerebral levels of IL-6, IL-10, TNF-α, ICAM-1, NF-κB p65, and total antioxidant capacity were assessed. These cerebral tissue levels and cerebral infarct size were significantly elevated in the control and vehicle groups compared to the sham group. Conversely, the total antioxidant capacity was significantly reduced in these groups. Coenzyme Q10 treatment resulted in a significant increase in IL-10 and total antioxidant capacity levels, along with a significant decrease in IL-6, ICAM-1, TNF-α, and NF-κB p65 levels. Histopathological analysis revealed a significant reduction in ischemic damage in the coenzyme Q10-treated group. Coenzyme Q10 has neuroprotective properties in rats subjected to cerebral ischemia/reperfusion injury, possibly through its anti-inflammatory and anti-oxidative effects.

Indexed as

Brain IschemiaNeuroprotective AgentsReperfusion InjuryAnimalsAntioxidantsInflammationIntercellular Adhesion Molecule-1Interleukin-10Interleukin-6MaleNF-kappa BOxidative StressRatsTumor Necrosis Factor-alphaUbiquinoneAntioxidantscoenzyme Q10Intercellular Adhesion Molecule-1Interleukin-10Interleukin-6Neuroprotective AgentsNF-kappa BTumor Necrosis Factor-alphaUbiquinoneCI/RICoenzyme Q10ICAM-1IL-10IL-6NF-κB p65TNF-αtotal anti-oxidant capacity

Identifiers

PMID38313176
PMCPMC10835568
OpenAlexW4394738543

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.